cardiogenesis.com president Pages on BioPortfolio:

Biotechnology News Septic Shock Sepsis chan. njtc. phillip. sepsi ...
Ten-year trends in the incidence and treatment of cardiogenic shock ... Slattery as vice president and general manager of its Medicare Advantage and ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=e...

Congestive Heart Failure: Major World Markets, Volume II: Devices ...
Cardiogenesis Corporation. Cordis Corporation/Biologics Delivery Systems. CoreValve, Inc. CryoCath Technologies, Inc. Cryocor, Inc. Datascope ...
http://www.bioportfolio.com/cgi-bin/acatalog/Congestive_Hear...

Biotechnology News Angina Search
13 /PRNewswire-FirstCall/ -- Cardiogenesis Corporation , a leading developer of surgical products used in the treatment of patients suffering from severe ...
http://www.bioportfolio.co.uk/Angina-news.htm...

BioPortfolio - Biocorporate Search Medical Device
CardioGenesis Corporation. Global leader in TMR and PMR (International markets only) An innovative and leading angiogenesis device company providing ...
http://www.bioportfolio.com/biocorporate/Medical%20Device-co...

BioPortfolio.com - BioWeb Pulmonary Edema Search
Noninvasive PSV May Obviate ICU Admission for Cardiogenic Pulmonary Edema ... A Ventilator Protocol for Fulminating Non-Cardiogenic Pulmonary Edema ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=s...

Congestive Heart Failure: Major World Markets, Volume II: Devices ...
... Inc. Cardiac Science Corporation; Cardiogenesis Corporation; Cordis Corporation/Biologics Delivery Systems; CoreValve, Inc. CryoCath Technologies,
Inc. ...
http://www.bioportfolio.com/cgi-bin/acatalog/info_1030.html...

Biotechnology News Antiphospholipid iga. elisa. titr. igm. ab. pt ...
AMDL, Inc. New President & CEO Douglas MacLellan to Present at Rodman & Renshaw ... Ten-year trends in the incidence and treatment of cardiogenic shock ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=e...

BioPortfolio - Pulmonary Edema
Noninvasive ventilation in acute cardiogenic pulmonary edema. The aim of this study was to describe the clinical features and management. ...
http://www.bioportfolio.com/indepth/Pulmonary_Edema.html...

BioPortfolio.com - BioWeb Syncope Fainting Search
Self Help Clearinghouse Neuro-Cardiogenic Syncope This information is provided as a resource and does not constitute an endorsement for any group. ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=s...

BioPortfolio - Intra-Aortic Balloon Pumping
Percutaneous ventricular assist devices for cardiogenic shock. ... Effects of Pyruvate in Patients With Cardiogenic Shock and Intra-Aortic Balloon ...
http://www.bioportfolio.com/indepth/Intra-Aortic_Balloon_Pum...

Results from other life science and pharmaceutical sites:

CardioGenesis Reports Results for the Fourth Quarter and Year ...
http://www.cardiogenesis.com CONTACT: Allen W. Hill, President and CEO, or Richard P. Powers, Executive Vice President and CFO, 408-328-8500; or ...
http://prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www...

Cardiogenesis Corporation Reports Third Quarter 2008 Results ...
Richard Lanigan, Cardiogenesis President stated, "To leverage the investments we have made in our sales organization, we are undertaking a major marketing ...
http://www.biospace.com/news_story.aspx?NewsEntityId=117389...

CardioGenesis Appoints New Board Member
Mr. Lange is a former Group Vice President of Marketing, Planning and ... said Allen W. Hill, CardioGenesis's president and chief executive officer. ...
http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=...

Cardiogenesis Corporation Receives FDA Approval for PEARL 5.0 ...
CONTACT: William R. Abbott, Senior Vice President and Chief Financial Officer, Cardiogenesis Corporation, +1-949-420-1800 ...
http://www.biospace.com/news_story.aspx?NewsEntityId=77239...

CardioGenesis Appoints Robert C. Strauss to Board of Directors
P. Powers, Vice President and CFO of CardioGenesis, 408-328-8500; or general information, Ann Trunko, or analysts, Kate Rajeck ...
http://prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www...

Cardiogenesis Corporation Announces Preliminary Clinical Results ...
"These initial clinical results utilizing the PHOENIX delivery system are very promising," stated Richard Lanigan, President of Cardiogenesis, ...
http://www.biospace.com/news_story.aspx?NewsEntityId=100140...

CardioGenesis Reports Results for the First Quarter Ended March 31 ...
"We continue to make significant progress in both the areas of ITMR and PMR," commented Allen W. Hill, CardioGenesis President and CEO. ...
http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=...

CardioGenesis Corporation Announces Submission of PMA Supplement ...
CONTACT: William R. Abbott, Senior Vice President and Chief FinancialOfficer of Cardiogenesis Corporation, +1-949-420-1800 ...
http://www.biospace.com/news_story.aspx?NewsEntityId=56032...

CardioGenesis Completes Phase II Axcis PMR Randomized Trial
CardioGenesis is currently conducting three, six and twelve month patient ... said Allen W. Hill, President and Chief Executive Officer of CardioGenesis. ...
http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=...

{1} Announces Submission Of IDE Protocol To {2} For PMC Clinical ...
In early June, Cardiogenesis received a Letter of Agreement from the FDA that ... Vice President,Chief Financial Officer of Cardiogenesis Corporation, ...
http://www.biospace.com/news_story.aspx?NewsEntityId=2052952...

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.